Furthermore, PRDM1 and IRF, which exhibit higher activity in CD8+ T cells, induce ferroptosis in cancer cells by inhibiting the transcription of GPX4 and driving the expression of transferrin receptor, respectively, thereby improving the TME (Song et al., 2024; Wu et al., 2024). The gene discussed is TRIM63; the disease is cancer.